|4Jul 27, 4:43 PM ET

HARDY REGINALD L 4

4 · Brickell Biotech, Inc. · Filed Jul 27, 2021

Insider Transaction Report

Form 4
Period: 2021-07-23
HARDY REGINALD L
DirectorChairman of the Board
Transactions
  • Purchase

    Common Stock

    2021-07-26$0.67/sh+100,000$67,420448,411 total
  • Purchase

    Common Stock

    2021-07-23$0.66/sh+100,000$66,230348,411 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    9,261
  • Common Stock

    (indirect: By Trust)
    17,260
  • Common Stock

    (indirect: By Spouse)
    21,826
  • Common Stock

    (indirect: By Self as General Partner)
    266,447
  • Common Stock

    (indirect: By Trust)
    17,260
Footnotes (2)
  • [F1]Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.66 to $0.6720 per share, resulting in a weighted average purchase price of $0.6623. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
  • [F2]Represents the purchase of 100,000 shares in multiple transactions, ranging in price from $0.671 to $0.678 per share, resulting in a weighted average purchase price of $0.6742. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.

Documents

1 file
  • 4
    wf-form4_162741854446247.xmlPrimary

    FORM 4